Table of Content

Chapter 1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
Chapter 2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations
Chapter 3. Market Determinants
3.1. Motivators
3.1.1. Increasing Prevalence of Liver Cancer
3.1.2. Government Support and Initiatives
3.1.3. Approval of Multiple Novel Drugs
3.1.4. Increasing Health Expenditure
3.2. Restraints
3.2.1. Complex Clinical Trials Process
3.2.2. High Treatment Cost
3.3. Opportunities
3.3.1. Growing Health Awareness
3.3.2. Presence of Strong Pipeline
Chapter 4. Market Segmentation
4.1. Global Liver Cancer Treatment Market by Treatment
4.1.1. Liver Cancer Surgery
4.1.2. Tumor Ablation
4.1.3. Embolization Therapy
4.1.4. Radiation Therapy
4.1.5. Targeted Therapy
4.1.6. Immunotherapy
4.1.7. Chemotherapy
4.2. Global Liver Cancer Treatment Market by End-User
4.2.1. Hospitals and Clinics
4.2.2. Research Centre
Chapter 5. Competitive Landscape
5.1. Key Strategy Analysis
5.2. Key Company Analysis
Chapter 6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
Chapter 7. Company Profiles
7.1. 4SC AG
7.2. Alnylam Pharmaceuticals, Inc.
7.3. ArQule, Inc.
7.4. Aveo Pharmaceuticals, Inc.
7.5. Bayer AG
7.6. Becton and Dickinson, Co.
7.7. Bristol-Myers Squibb, Co.
7.8. Celsion Corp.
7.9. Dicerna Pharmaceuticals, Inc.
7.10. Eli Lilly and Co.
7.11. Exelixis, Inc.
7.12. F. Hoffmann-La Roche, Ltd.
7.13. FibroGen, Inc.
7.14. General Electric Co.
7.15. Merck KGaA
7.16. Novartis International AG
7.17. Nymox Pharmaceutical Corp.
7.18. Pfizer, Inc.
7.19. SMC Laboratories, Inc.
7.20. Thermo Fisher Scientific, Inc.



List of Figures


FIGURE # 1 GLOBAL LIVER CANCER TREATMENT MARKET SHARE BY TREATMENT, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL LIVER CANCER TREATMENT MARKET SHARE BY END-USER, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL LIVER CANCER TREATMENT MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
FIGURE # 4 NORTH AMERICAN LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 US LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 EUROPEAN LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 UK LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 GERMANY LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 FRANCE LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 ITALY LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 ROE LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 ASIA-PACIFIC LIVER CANCER TREATMENT MARKET SIZE, 2018-2023($ MILLION)
FIGURE # 15 CHINA LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 INDIA LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 JAPAN LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 18 REST OF ASIA-PACIFIC LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 19 REST OF WORLD LIVER CANCER TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)

 

List of Tables


TABLE # 1 GLOBAL LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS, BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL LIVER CANCER SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL EMBOLIZATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL TARGETED THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS, BY END-USER, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL RESEARCH CENTRE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 13 NORTH AMERICAN LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 14 NORTH AMERICAN LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 15 NORTH AMERICAN LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 16 EUROPEAN LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 17 EUROPEAN LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 18 EUROPEAN LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 19 ASIA-PACIFIC LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 20 ASIA-PACIFIC LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
TABLE # 21 ASIA-PACIFIC LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 22 REST OF THE WORLD LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 23 REST OF THE WORLD LIVER CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)